Integra LifeSciences Corp. CereLink ICP Monitor; Catalog No. 826820, 826820P. Intracranial pressure monitor. Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
CereLink ICP Monitor; Catalog No. 826820, 826820P. Intracranial pressure monitor.
Brand
Integra LifeSciences Corp.
Lot Codes / Batch Numbers
UDI-DI- 10381780533778, All serial numbers.
Products Sold
UDI-DI- 10381780533778; All serial numbers.
Integra LifeSciences Corp. is recalling CereLink ICP Monitor; Catalog No. 826820, 826820P. Intracranial pressure monitor. due to Integra has received complaints associated with ICP readings drifting to -50 mmHg (out-of-range) and may manifest an error message "sensor or extensio. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Integra has received complaints associated with ICP readings drifting to -50 mmHg (out-of-range) and may manifest an error message "sensor or extension cable failure!" The firm has found that this is caused by electrical interference from a component of the monitor's circuit board and from the environment.
Recommended Action
Per FDA guidance
A recall notification titled 1st NOTIFICATION - URGENT: VOLUNTARY MEDICAL DEVICE CORRECTION, dated June 22, 2022, was sent by mail. This communicated troubleshooting techniques if an out-of-range reading is encountered when utilizing the Codman CereLink System, while Integra finalized a root cause investigation. A second notification, dated August 23, 2022, for this recall states that Integra is now conducting a removal of Codman CereLink ICP Monitors. Customers are asked to discontinue use of affected devices as soon as possible and remove the devices from service. If an affected device is being used on a patient, continued use should only be determined by an individual risk-benefit analysis by the responsible attending clinician. If the recalled device continues to be used on a patient, the patient needs to be carefully monitored and ensure cable management. If a progressive decline in ICP readings is observed, use another monitoring system for continued patient case as soon as possible. Once patient care is complete, discontinue use of the monitor and remove it from service. As CereLink ICP Monitors are removed from use, a sales representative will facilitate the return of the affected monitor. Complete the Acknowledgement Form and return it to your Account Manager or email it to FCA3@integralife.com or Fax the form to 1-609-750-4220. Keep a copy of the recall notification for your records. Any questions, contact your Integra Account Manager, Clinical Specialist, or Technical Support at technical.support@integralife.com or by phone at 888-772-7378.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026